Skip to content

Clinical Study of Fecal Microbiota Transplantation for Irritable Bowel Syndrome

Clinical Study of Fecal Microbiota Transplantation for Irritable Bowel Syndrome

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300077855
Enrollment
Unknown
Registered
2023-11-22
Start date
2023-11-22
Completion date
Unknown
Last updated
2023-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Irritable Bowel Syndrome

Interventions

Treatment group:healthy donor FMT under colonoscopy

Sponsors

The First Medical Center, Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 70 Years

Inclusion criteria

Inclusion criteria: ?Accord with Rome IV standards:The course of disease is more than 6 months, Recurrent abdominal pain, at least one day a week, accompanied by 2 or more of the following abnormal changes in the past 3 months:1) Abdominal pain associated with defecation; 2) accompanied by a change in the frequency of defecation; 3) accompanied by changes in fecal character ? The main symptoms were diarrhea, constipation and abdominal pain; Lack of morphological changes and biochemical abnormalities that explain symptoms; ?Volunteer for fecal microbiota transplantation

Exclusion criteria

Exclusion criteria: ?Organic diseases were excluded by physical examination, laboratory examination, B ultrasound, endoscopy, etc. ? Had a history of abdominal surgery; ? Diarrhea or constipation caused by other diseases; ? A history of neuropsychiatry and alcohol abuse; ? Had taken sedative, antianxiety and antidepressant drugs in the last 1 month; ? Pregnant and lactating women; ? Accompanied by other systemic chronic or serious diseases, such as severe liver disease, heart disease, diabetes, etc.

Design outcomes

Primary

MeasureTime frame
IBS-SSS;

Secondary

MeasureTime frame
Adverse reactions associated with FMT were recorded and graded;IBS-QOL;HADS;Changes of biochemical and physiological indicators;

Countries

China

Contacts

Public ContactPan Fei

The First Medical Center, Chinese PLA General Hospital

panfei@plagh.org+86 135 5272 2960

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026